Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2455 posts found.

Redx Confirms Proposed Business Combination with Jounce has Formally Lapsed

April 3, 2023 Business Services

Alderley Park, UK, 3 April 2023 Redx (AIM:REDX), the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, …
News
Press release

Almirall: The New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD) publish Ph3 data evaluating lebrikizumab efficacy and safety in moderate-to-severe atopic dermatitis

March 31, 2023 Business Services Almirall, Dermatology, dermatology, lebrikizumab

BARCELONA, Spain. March 31, 2023 – Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, announced today the …
News
Press release

HUTCHMED Completes Rolling Submission of NDA to U.S. FDA for Fruquintinib for the Treatment of Refractory Metastatic Colorectal Cancer

March 31, 2023 Business Services

Hong Kong, Shanghai & Florham Park, NJ — Friday, March 31, 2023: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM, HKEX:​13) today announces that …
News
Press release

Expansion of Scientific Affairs Group

March 30, 2023 Business Services

Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an …
News
Press release

Roz Bekker appointed Managing Director of Janssen UK & Ireland

March 30, 2023 Business Services

High Wycombe, UK, 30 March 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson are pleased to introduce Roz …
Appointment

Granular Therapeutics to accelerate development of next-generation pipeline for treating mast cell driven diseases

March 30, 2023 Business Services

London, UK, March 30, 2023 – Granular Therapeutics, (Granular) a private biotech company specialising in precision biologic therapies for treating …
News
Press release

Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics

March 30, 2023 Business Services

Netanya, Israel, March 30, 2023 – Trobix Bio, a company utilizing CRISPR, phage, and synthetic biology technologies to develop advanced …
News
Press release

PHARMANOVIA EXPANDS EXCLUSIVE LICENSING COLLABORATION WITH AQUESTIVE THERAPEUTICS FOR DIAZEPAM BUCCAL FILM

March 30, 2023 Business Services

Basildon, UK – For immediate release, 27 March 2023   Pharmanovia, a global pharmaceutical company that revitalises, extends and expands …
News
Press release

Unite Health: Thousands Honor Pandemic ‘Influencers’ Through COVID-19 Social Media Awards

March 30, 2023 Business Services

  London, UK | In a global display of appreciation, thousands of people are recognizing social media influencers who used …
News
Press release

Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B

March 28, 2023 Business Services

OXFORD, United Kingdom, March 28, 2023 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company focused on the …
News
Press release

Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry

March 28, 2023 Business Services

Milan, Italy, March 28, 2023, 12:30 pm CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company …
News
Press release

TEZSPIRE▼(TEZEPELUMAB) TO BE RECOMMENDED BY NICE AS AN ADD-ON TREATMENT FOR SEVERE UNCONTROLLED ASTHMA

March 28, 2023 Business Services

London, UK, Tuesday 28 March 2023 – AstraZeneca today announced that the National Institute for Health and Care Excellence (NICE) …
News
Press release

Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV

March 28, 2023 Business Services

ST. GALLEN, Switzerland, March 28, 2023 /PRNewswire/ — Vifor Fresenius Medical Care Renal Pharma (VFMCRP) is pleased to announce that …
News
Press release

iOnctura awarded UK’s MHRA Innovation Passport for entry into innovative licensing and access pathway (ILAP)

March 28, 2023 Business Services

Geneva, Switzerland and Amsterdam, The Netherlands, 28 March – iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients …
News
Press release

Sofinnova Partners launches Digital Medicine Strategy

March 28, 2023 Business Services

PARIS, France – March 28, 2023 – Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital firm based in …
News
Press release
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026